427 research outputs found

    Statistically Motivated Second Order Pooling

    Get PDF
    Second-order pooling, a.k.a.~bilinear pooling, has proven effective for deep learning based visual recognition. However, the resulting second-order networks yield a final representation that is orders of magnitude larger than that of standard, first-order ones, making them memory-intensive and cumbersome to deploy. Here, we introduce a general, parametric compression strategy that can produce more compact representations than existing compression techniques, yet outperform both compressed and uncompressed second-order models. Our approach is motivated by a statistical analysis of the network's activations, relying on operations that lead to a Gaussian-distributed final representation, as inherently used by first-order deep networks. As evidenced by our experiments, this lets us outperform the state-of-the-art first-order and second-order models on several benchmark recognition datasets.Comment: Accepted to ECCV 2018. Camera ready version. 14 page, 5 figures, 3 table

    On the generalized vector F-implicit complementarity problems and vector F-implicit variational inequality problems

    Get PDF
    In this paper, we introduce and analyze some new classes of generalized vector-F implicit complementarity problems and the general mixed vector-F variational inequalities. Under suitable conditions, we prove the equivalences between these new problems. We establish several existence theorems for these classes of vector-F complementarity and general mixed vector-F variational inequalities using a new version of the Fan-KKM theorem in Hausdorff topological vector spaces, and without even using the classical assumptions in this context, like monotonicity or continuity. Results obtained in this paper represent significant improvement and refinement of the previously known results

    New kinds of generalized variational-like inequality problems in topological vector spaces

    Get PDF
    AbstractIn this work, we consider a generalized nonlinear variational-like inequality problem, in topological vector spaces, and, by using the KKM technique, we prove an existence theorem. Our result extends a theorem of Ahmad and Irfan [R. Ahmad, S.S. Irfan, On the generalized nonlinear variational-like inequality problems, Appl. Math. Lett. 19 (2006) 294–297]

    The relative frequency, clinical and laboratory findings of adult glomerulonephritidies in Tehran

    Get PDF
    Background: Renal diseases information is population-based and has great geographic variability. Due to the lack of national renal data registry system, there is no information on the prevalence rate, and clinical and laboratory features of various glomerulonephritidies (GNs) in Iran. Methods: In a retrospective cross sectional study, we analyzed 462 adult renal biopsies in Hashemi Nejad hospital, Tehran, Iran. We determined the prevalence rate and the frequency of different clinical and laboratory findings in patients with different GNs. We also compared our results with the reports from other countries. Results: There were 267(57.8) males and 195(42.2) females. The mean age (± SD) was 33.6 ± 15.7 (range, 13-75) years old. After exclusion of 55 biopsies with pathologies other than GNs and in the remaining 407 biopsies, membranous glomerulopathy (MGN) was the most common GN (23.6), followed by IgAN (13.5), membranoproliferative GN (11.5), systemic lupus nephritis (10.6), focal segmental glomerulosclerosis (10.3), and minimal change disease (9.8). These 6 GNs comprised the majority (79.4) of all GNs. Conclusion: MGN is the most common form of GN, followed by IgAN, MPGN, SLE-GN, FSGS and MCD in adult patients in our study. The multi-center studies with a larger sample size are needed for more comprehensive data in Iranian population

    Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

    Get PDF
    Epidermal growth factor receptor (EGFR) is a cell surface molecule and member of the ErbB family of receptor tyrosine kinases. Its activation leads to proliferation, antiapoptosis, and metastatic spread, making inhibition of this pathway a compelling target. In recent years, an increasing number of clinical trials in the management of solid malignancies have become available indicating the clinical efficacy of anti-EGFR monoclonal antibodies and oral small molecule tyrosine kinase inhibitors (TKIs). This review addresses frequently used EGFR inhibitors, summarizes clinical efficacy data of these new therapeutic agents, and discusses their associated toxicity and management

    A Generalization of a Greguš Fixed Point Theorem in Metric Spaces

    Get PDF
    We first introduce a new class of contractive mappings in the setting of metric spaces and then we present certain Greguš type fixed point theorems for such mappings. As an application, we derive certain Greguš type common fixed theorems. Our results extend Greguš fixed point theorem in metric spaces and generalize and unify some related results in the literature. An example is also given to support our main result

    Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial

    Get PDF
    Objective. To investigate the safety and efficacy of MLC601 (NeuroAid) as a traditional Chinese medicine on motor recovery after ischemic stroke. Methods. This study was a double-blind, placebo-controlled clinical trial on 150 patients with a recent (less than 3 month) ischemic stroke. All patients were given either MLC601 (100 patients) or placebo (50 patients), 4 capsules 3 times a day, as an add-on to standard stroke treatment for 3 months. Results. Sex, age, elapsed time from stroke onset, and risk factors in the treatment group were not significantly different from placebo group at baseline (P > .05). Repeated measures analysis showed that Fugl-Meyer assessment was significantly higher in the treatment group during 12 weeks after stroke (P < .001). Good tolerability to treatment was shown, and adverse events were mild and transient. Conclusion. MLC601 showed better motor recovery than placebo and was safe on top of standard ischemic stroke medications especially in the severe and moderate cases
    corecore